0
Upcoming Allied Market Research
2023
Amlodipine Market

Amlodipine Market

by Type (2.5mg Tablets, 5mg Tablets, 10mg Tablets), by Application (High Blood Pressure, Heart Diseases) : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50558
Pages: NA
May 2023 | 30 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 
Amlodipine is a medication used to treat high blood pressure and certain types of angina (chest pain). It is a type of calcium channel blocker, which means it works by relaxing the blood vessels, making it easier for the heart to pump blood around the body. Amlodipine is usually taken once a day in tablet form, with or without food. The dosage will depend on the individual and their medical condition. It's important to take the medication exactly as prescribed by a healthcare professional, and not to stop taking it without consulting a doctor.
Amlodipine is a widely used medication for the treatment of hypertension (high blood pressure) and angina. It is available under various brand names, including Norvasc, Istin, and Amloc, among others. Amlodipine is a relatively inexpensive medication and is available in both generic and brand-name forms. Amlodipine is one of the most commonly prescribed medications for the treatment of hypertension. It is included in the World Health Organization's List of Essential Medicines, which is a list of the most important medications needed in a basic health system.
Hypertension is a complex condition, that often requires multiple medications to achieve optimal blood pressure control. Amlodipine is commonly used in combination with other medications, such as ACE inhibitors or ARBs, to achieve better blood pressure control in patients with hypertension. ACE inhibitors and ARBs work by blocking the action of the hormone angiotensin II, which can cause blood vessels to constrict and blood pressure to rise. Amlodipine works by relaxing the blood vessels, making it easier for the heart to pump blood around the body. When used in combination, these medications can work synergistically to lower blood pressure and reduce the risk of complications associated with hypertension.
The growing use of combination therapies for the treatment of hypertension is expected to drive the demand for amlodipine. In recent years, there has been a shift towards using combination therapies earlier in the course of treatment, rather than waiting until blood pressure is difficult to control with a single medication. This is because combination therapies can provide better blood pressure control and reduce the risk of complications associated with hypertension. In addition to ACE inhibitors and ARBs, amlodipine is also commonly used in combination with diuretics, beta-blockers, and other medications to achieve better blood pressure control. The increasing use of these combination therapies is expected to drive the demand for amlodipine, which is a commonly used medication in these regimens. Overall, the growing use of combination therapies for the treatment of hypertension is a significant driver of the demand for amlodipine, and this trend is expected to continue as healthcare providers and patients seek to achieve better blood pressure control and reduce the risk of complications associated with hypertension.
Furthermore, amlodipine is a relatively inexpensive medication compared to many other medications used to treat hypertension. This makes it an attractive option for both healthcare providers and patients, as it can help keep healthcare costs down while still providing effective treatment for hypertension. As healthcare costs continue to rise, the cost-effectiveness of amlodipine is expected to drive its continued use. Healthcare providers are under increasing pressure to provide cost-effective treatments, and amlodipine is often one of the first-line medications used to treat hypertension due to its cost-effectiveness. In addition to being cost-effective, amlodipine is also widely available in both generic and brand-name forms, which can further help to reduce costs for patients and healthcare providers. The availability of a generic form of a medication can often help to drive down the overall cost of treatment, making it more affordable for patients and healthcare systems.
New product launches to flourish in the market
In 2020, Lupin Pharmaceuticals launched a new amlodipine and olmesartan medoxomil combination tablet, which is used to treat hypertension. In 2019, Sandoz Inc. received approval from the FDA for its amlodipine and valsartan combination tablet, which is also used to treat hypertension. Also, in 2018, Torrent Pharmaceuticals launched a new amlodipine and telmisartan combination tablet, which is also used to treat hypertension.
Segment Overview: 
By Type: The amlodipine market is divided into 2.5mg tablets, 5mg tablets and 10mg tablets. The 2.5mg tablet strength is often used for patients who require a lower dose of amlodipine, such as the elderly or those who have other health conditions that may increase their sensitivity to the medication. The 5mg and 10mg tablet strengths are often used for patients who require a higher dose of amlodipine to achieve optimal blood pressure control. Different tablet strengths may also be used at different stages of treatment, as patients may start with a lower dose and then gradually increase to a higher dose if needed. For example, a patient may start with a 2.5mg tablet once daily and then increase to a 5mg or 10mg tablet if their blood pressure is not adequately controlled.
 
By Application: The amlodipine market is divided into high blood pressure and heart diseases. Amlodipine is primarily used for the treatment of high blood pressure (hypertension), which is a common condition that affects many people worldwide. Hypertension is a major risk factor for heart disease, stroke, and other cardiovascular diseases, so the use of amlodipine can help to reduce the risk of these conditions. While amlodipine is primarily indicated for the treatment of hypertension, it may also be used in the treatment of certain heart conditions, such as angina pectoris and coronary artery disease. In these cases, amlodipine is often used to improve blood flow to the heart and reduce the workload on the heart, which can help to reduce symptoms and improve overall cardiovascular health.
 
By Region: The Asia Pacific amlodipine market is one of the fastest-growing markets for amlodipine in the world. The market is expected to experience significant growth in the coming years due to several factors.
 
One of the primary reasons of growth in the Asia Pacific amlodipine market is the high prevalence of hypertension in the region. Hypertension is a major health concern in many countries   of the Asia Pacific region, and its prevalence is expected to increase in the coming years due to factors such as aging populations and changing lifestyles. Amlodipine is an effective and commonly used medication for the treatment of hypertension, which is expected to drive/ increase the demand for the drug in the region.
 
Another factor driving the growth of the Asia Pacific amlodipine market is the increasing availability and affordability of healthcare in the region. As healthcare infrastructure improves and access to medical services becomes more widespread, more patients are able to receive a diagnosis of hypertension and access treatment with medications like amlodipine. The growing awareness of hypertension and its associated risks is also expected to contribute to the growth of the amlodipine market in the Asia Pacific region. As more people become aware of the importance of managing blood pressure and reducing the risk of heart disease and other cardiovascular conditions, the demand for medications like amlodipine is likely to increase.
 
Competitive analysis and profiles of the major players in the amlodipine market, such as Aurobindo Pharma Ltd,. Epic Pharma, Macleods Pharmaceuticals ltd., Pfizer Inc., Alkem Laboratories Ltd. Mylan N V, Dr. Reddy's, CR     Pharmaceuticals , Cipla Ltd, Zydus Wellness Ltd, and Tianjin Chasesun Pharmaceutical Co., Ltd are included in the report. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the amlodipine market.

Amlodipine Market Report Highlights

Aspects Details
By Type
  • 2.5mg Tablets
  • 5mg Tablets
  • 10mg Tablets
By Application
  • High Blood Pressure
  • Heart Diseases
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Aurobindo Pharma Ltd, epic pharma, macleods pharmaceuticals ltd., Pfizer Inc., Alkem Laboratories Ltd, Mylan Nv, Dr. Reddy's, CR Pharmaceutical, Cipla Ltd, Zydus Wellness Ltd, Tianjin Chasesun Pharmaceutical Co., Ltd
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Amlodipine Market

Start reading.
This Report and over 19,981+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers